| 2k7m |
Structure of the Connexin40 Carboxyl terminal Domain |
38.9 |
149.5 |
SOLUTION NMR |
REASONABLE
|
| 2k7n |
Solution structure of the PPIL1 bound to a fragment of SKIP |
17.1 |
60.2 |
SOLUTION NMR |
GOOD
|
| 2k7o |
Ca2+-S100B, refined with RDCs |
18.6 |
60.3 |
SOLUTION NMR |
GOOD
|
| 2k7p |
Filamin A Ig-like domains 16-17 |
19.3 |
50.1 |
SOLUTION NMR |
REASONABLE
|
| 2k7q |
Filamin A Ig-like domains 18-19 |
20.9 |
71.7 |
SOLUTION NMR |
GOOD
|
| 2k7r |
N-terminal domain of the Bacillus subtilis helicase-loading protein DnaI |
18.1 |
76.8 |
SOLUTION NMR |
REASONABLE
|
| 2k7s |
Human ARNT C-Terminal PAS Domain, 3 Residue IB slip |
13.8 |
45.5 |
SOLUTION NMR |
GOOD
|
| 2k7v |
Deletions in a surface loop divert the folding of a protein domain into a metastable dimeric form |
39.9 |
103.7 |
SOLUTION NMR |
REASONABLE
|
| 2k7w |
BAX Activation is Initiated at a Novel Interaction Site |
18.9 |
70.3 |
SOLUTION NMR |
GOOD
|
| 2k7x |
solution structure of C-terminal domain of SARS-CoV main protease |
14.8 |
65.0 |
SOLUTION NMR |
REASONABLE
|
| 2k7y |
Solution fold of HIV-1 Virus protein U cytoplasmic domain in the presence of DPC micelles |
9.7 |
32.1 |
SOLUTION NMR |
GOOD
|
| 2k7z |
Solution Structure of the Catalytic Domain of Procaspase-8 |
19.3 |
65.6 |
SOLUTION NMR |
GOOD
|
| 2k84 |
Solution Structure of the equine infectious anemia virus p9 GAG protein |
12.2 |
33.5 |
SOLUTION NMR |
REASONABLE
|
| 2k85 |
p190-A RhoGAP FF1 domain |
11.5 |
37.7 |
SOLUTION NMR |
GOOD
|
| 2k86 |
Solution Structure of FOXO3a Forkhead domain |
14.9 |
54.2 |
SOLUTION NMR |
GOOD
|
| 2k87 |
NMR STRUCTURE OF A PUTATIVE RNA BINDING PROTEIN (SARS1) FROM SARS CORONAVIRUS |
14.4 |
37.5 |
SOLUTION NMR |
REASONABLE
|
| 2k88 |
;Association of subunit d (Vma6p) and E (Vma4p) with G (Vma10p) and the NMR solution structure of subunit G (G1-59) of the Saccharomyces cerevisiae V1VO ATPase
; |
24.3 |
101.0 |
SOLUTION NMR |
REASONABLE
|
| 2k89 |
Solution structure of a novel Ubiquitin-binding domain from Human PLAA (PFUC, Gly76-Pro77 cis isomer) |
13.8 |
48.7 |
SOLUTION NMR |
GOOD
|
| 2k8a |
Solution structure of a novel Ubiquitin-binding domain from Human PLAA (PFUC, Gly76-Pro77 trans isomer) |
14.0 |
50.6 |
SOLUTION NMR |
GOOD
|
| 2k8b |
Solution structure of PLAA family ubiquitin binding domain (PFUC) cis isomer in complex with ubiquitin |
17.6 |
61.3 |
SOLUTION NMR |
GOOD
|
| 2k8c |
Solution structure of PLAA family ubiquitin binding domain (PFUC) trans isomer in complex with ubiquitin |
17.9 |
60.9 |
SOLUTION NMR |
GOOD
|
| 2k8d |
Solution structure of a zinc-binding methionine sulfoxide reductase |
16.3 |
57.5 |
SOLUTION NMR |
GOOD
|
| 2k8e |
;Solution NMR Structure of protein of unknown function yegP from E. coli. Ontario Center for Structural Proteomics target EC0640_1_123 Northeast Structural Genomics Consortium Target ET102.
; |
14.2 |
47.5 |
SOLUTION NMR |
GOOD
|
| 2k8f |
Structural Basis for the Regulation of p53 Function by p300 |
16.4 |
64.3 |
SOLUTION NMR |
REASONABLE
|
| 2k8g |
Solution structure of RRM2 domain of PABP1 |
13.8 |
48.3 |
SOLUTION NMR |
GOOD
|
| 2k8h |
Solution structure of SUMO from Trypanosoma brucei |
16.5 |
45.1 |
SOLUTION NMR |
REASONABLE
|
| 2k8i |
Solution structure of E.Coli SlyD |
23.3 |
89.2 |
SOLUTION NMR |
GOOD
|
| 2k8j |
Solution structure of HCV p7 tm2 |
13.9 |
59.5 |
SOLUTION NMR |
REASONABLE
|
| 2k8m |
S100A13-C2A binary complex structure |
34.6 |
120.9 |
SOLUTION NMR |
REASONABLE
|
| 2k8o |
Solution structure of integrin Alpha L |
10.6 |
36.5 |
SOLUTION NMR |
GOOD
|
| 2k8p |
;Characterisation of the structural features and interactions of sclerostin: molecular insight into a key regulator of Wnt-mediated bone formation
; |
58.0 |
287.1 |
SOLUTION NMR |
REASONABLE
|
| 2k8q |
NMR Structure of Shq1p N-terminal domain |
23.2 |
63.4 |
SOLUTION NMR |
REASONABLE
|
| 2k8r |
Solution structure of human acidic fibroblast growth factor in complex with anti-angiogenic drug inositol hexaphosphate (IP6) |
14.4 |
42.4 |
SOLUTION NMR |
EXCELLENT
|
| 2k8s |
;Solution NMR structure of dimeric thioredoxin-like protein NE0084 from Nitrosomonas europea: Northeast Structural Genomics Target NeT6
; |
16.1 |
48.7 |
SOLUTION NMR |
GOOD
|
| 2k8t |
Solution NMR structure of trans-4-hydroxynonenal derived dG adduct of (6R,8S,11R)-configuration opposite dC |
13.8 |
46.9 |
SOLUTION NMR |
GOOD
|
| 2k8u |
Solution NMR structure of trans-4-hydroxynonenal derived dG adduct of (6S,8R,11S)-configuration matched with dC |
13.8 |
45.5 |
SOLUTION NMR |
GOOD
|
| 2k8v |
Solution structure of Oxidised ERp18 |
16.9 |
45.2 |
SOLUTION NMR |
REASONABLE
|
| 2k8x |
;GlyTM1b(1-19)zip: A Chimeric Peptide Model of the N-Terminus of a Rat Short Alpha-Tropomyosin with the N-Terminus Encoded by Exon 1b in Complex with TM9d(252-284), a Peptide Model Containing the C Terminus of Alpha-Tropomyosin Encoded by Exon 9d
; |
17.2 |
68.5 |
SOLUTION NMR |
GOOD
|
| 2k8y |
Solution NMR Structure of Cgi121 from Methanococcus jannaschii. Northeast Structural Genomics Consortium Target MJ0187 |
15.7 |
54.5 |
SOLUTION NMR |
GOOD
|
| 2k8z |
Dimeric solution structure of the DNA loop d(TCGTTGCT) |
9.9 |
40.7 |
SOLUTION NMR |
GOOD
|
| 2k90 |
Dimeric solution structure of the DNA loop d(TGCTTCGT) |
9.5 |
34.9 |
SOLUTION NMR |
GOOD
|
| 2k91 |
Enhancing the activity of insulin by stereospecific unfolding |
10.6 |
35.3 |
SOLUTION NMR |
GOOD
|
| 2k92 |
Structural modification of acyl carrier protein by butyryl group |
11.8 |
38.1 |
SOLUTION NMR |
GOOD
|
| 2k93 |
Structural modification of acyl carrier protein by butyryl group |
11.9 |
38.4 |
SOLUTION NMR |
GOOD
|
| 2k94 |
Structural modification of acyl carrier protein by butyryl group |
11.6 |
38.4 |
SOLUTION NMR |
GOOD
|
| 2k95 |
Solution structure of the wild-type P2B-P3 pseudoknot of human telomerase RNA |
17.5 |
62.9 |
SOLUTION NMR |
GOOD
|
| 2k96 |
Solution structure of the RDC-refined P2B-P3 pseudoknot from human telomerase RNA (delta U177) |
17.0 |
46.2 |
SOLUTION NMR |
REASONABLE
|
| 2k97 |
Dimeric solution structure of the cyclic octamer d(pCGCTCCGT) |
10.0 |
36.6 |
SOLUTION NMR |
GOOD
|
| 2k98 |
Helical hairpin structure of potent antimicrobial peptide MSI-594 in the presence of Lipopolysaccharide micelle |
7.4 |
28.4 |
SOLUTION NMR |
REASONABLE
|
| 2k9a |
The Solution Structure of the Arl2 Effector, BART |
18.8 |
48.8 |
SOLUTION NMR |
REASONABLE
|